These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 34465524)
1. Pharmacist-provided SARS-CoV-2 testing targeting a majority-Hispanic community during the early COVID-19 pandemic: Results of a patient perception survey. Patel J; Christofferson N; Goodlet KJ J Am Pharm Assoc (2003); 2022; 62(1):187-193. PubMed ID: 34465524 [TBL] [Abstract][Full Text] [Related]
2. Health Center Testing for SARS-CoV-2 During the COVID-19 Pandemic - United States, June 5-October 2, 2020. Romero L; Pao LZ; Clark H; Riley C; Merali S; Park M; Eggers C; Campbell S; Bui C; Bolton J; Le X; Fanfair RN; Rose M; Hinckley A; Siza C MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1895-1901. PubMed ID: 33332299 [TBL] [Abstract][Full Text] [Related]
3. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information. Hoti K; Jakupi A; Hetemi D; Raka D; Hughes J; Desselle S Int J Clin Pharm; 2020 Aug; 42(4):1197-1206. PubMed ID: 32524513 [TBL] [Abstract][Full Text] [Related]
4. Assessing Community Pharmacists' Perception on Readiness to Initiate Point-of-Care Testing for SARS-CoV-2 in New York State During the Pandemic. Ngwu RO; Lindeau R; Bielecki LM; Daly CJ J Pharm Pract; 2024 Apr; 37(2):324-334. PubMed ID: 36242519 [No Abstract] [Full Text] [Related]
5. A qualitative analysis of student pharmacists' perceptions working in community settings during the COVID-19 pandemic. Bingham JM; Maldonado T; Axon DR Curr Pharm Teach Learn; 2024 Sep; 16(9):102104. PubMed ID: 38789297 [TBL] [Abstract][Full Text] [Related]
6. Optimal Management of the Public and Patients by Pharmacists in the Era of COVID-19: An Evidence-Based Review and Practical Recommendations. Song Z; Hu Y; Ren Z; Wang G; Liu S; Zheng S; Yang L; Zhao R Front Public Health; 2021; 9():758325. PubMed ID: 35087781 [No Abstract] [Full Text] [Related]
7. Public perceptions about pharmacists' role in prescribing, providing education and delivering medications during COVID-19 pandemic era. Alhamad H; Abu-Farha R; Albahar F; Jaber D Int J Clin Pract; 2021 Apr; 75(4):e13890. PubMed ID: 33280210 [TBL] [Abstract][Full Text] [Related]
8. Community Pharmacists Roles During the COVID-19 Pandemic. Hess K; Bach A; Won K; Seed SM J Pharm Pract; 2022 Jun; 35(3):469-476. PubMed ID: 33317371 [TBL] [Abstract][Full Text] [Related]
9. Health equity in COVID-19 testing among patients of a large national pharmacy chain. Singh T; Smith-Ray RL; Ogunkoya E; Shah A; Harris DA; Hayes KN; Mor V Front Public Health; 2024; 12():1422914. PubMed ID: 39324167 [TBL] [Abstract][Full Text] [Related]
10. Pharmacists' Willingness to Provide Coronavirus Disease (COVID-19) Services and the Needs to Support COVID-19 Testing, Management, and Prevention. Nguyen E; Owens CT; Daniels T; Boyle J; Robinson RF J Community Health; 2021 Aug; 46(4):752-757. PubMed ID: 33156454 [TBL] [Abstract][Full Text] [Related]
11. New Jersey Pharmacists' Perceptions on Performing COVID-19 Testing in Community Pharmacy Practice Sites. Brust-Sisti LA; Armanious ME; Ohlinger K; Patel J; Lodhia T; Sturgill MG; Volino LR J Pharm Pract; 2023 Aug; 36(4):853-860. PubMed ID: 35357961 [TBL] [Abstract][Full Text] [Related]
12. Perceptions of Spanish-speaking clientele of patient care services in a community pharmacy. Olenik NL; Gonzalvo JD; Snyder ME; Nash CL; Smith CT Res Social Adm Pharm; 2015; 11(2):241-52. PubMed ID: 25103185 [TBL] [Abstract][Full Text] [Related]
13. Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19. Rosales R; Janssen T; Yermash J; Yap KR; Ball EL; Hartzler B; Garner BR; Becker SJ J Subst Abuse Treat; 2022 Jan; 132():108648. PubMed ID: 34742607 [TBL] [Abstract][Full Text] [Related]
14. The coping strategies of community pharmacists and pharmaceutical services provided during COVID-19 in Malaysia. Kua KP; Lee SWH Int J Clin Pract; 2021 Dec; 75(12):e14992. PubMed ID: 34710264 [TBL] [Abstract][Full Text] [Related]
15. Pharmacists' experience, competence and perception of telepharmacy technology in response to COVID-19. Muflih SM; Al-Azzam S; Abuhammad S; Jaradat SK; Karasneh R; Shawaqfeh MS Int J Clin Pract; 2021 Jul; 75(7):e14209. PubMed ID: 33819372 [TBL] [Abstract][Full Text] [Related]
16. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study. Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978 [TBL] [Abstract][Full Text] [Related]
17. Community pharmacists' perceptions, attitudes and barriers towards pharmacist-led minor ailment services in Malaysia. Selvaraj A; Redzuan AM; Hatah E Int J Clin Pharm; 2020 Apr; 42(2):777-785. PubMed ID: 32006142 [TBL] [Abstract][Full Text] [Related]
18. Increases in SARS-CoV-2 Test Positivity Rates Among Hispanic People in a Northern California Health System. Rodriguez F; Coquet J; Harrington R; Hernandez-Boussard T Public Health Rep; 2021; 136(5):543-547. PubMed ID: 34161176 [TBL] [Abstract][Full Text] [Related]
19. Pharmacists' Preparedness to Patients Education at the Time of Pandemic-A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland. Cerbin-Koczorowska M; Waszyk-Nowaczyk M; PrzymuszaĆa P Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32932684 [TBL] [Abstract][Full Text] [Related]
20. The Relationship between Customers and Community Pharmacies during the COVID-19 (SARS-CoV-2) Pandemic: A Survey from Italy. Baratta F; Ciccolella M; Brusa P Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]